KR20160082162A - Method for Venegar Using Aronia and Venegar Beverage Using Thereof - Google Patents
Method for Venegar Using Aronia and Venegar Beverage Using Thereof Download PDFInfo
- Publication number
- KR20160082162A KR20160082162A KR1020140195266A KR20140195266A KR20160082162A KR 20160082162 A KR20160082162 A KR 20160082162A KR 1020140195266 A KR1020140195266 A KR 1020140195266A KR 20140195266 A KR20140195266 A KR 20140195266A KR 20160082162 A KR20160082162 A KR 20160082162A
- Authority
- KR
- South Korea
- Prior art keywords
- acetic acid
- fermentation
- aronia
- concentration
- vinegar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 241001444063 Aronia Species 0.000 title claims abstract description 77
- 238000000034 method Methods 0.000 title claims abstract description 20
- 235000013361 beverage Nutrition 0.000 title claims description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims abstract description 420
- 229960000583 acetic acid Drugs 0.000 claims abstract description 141
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 116
- 238000000855 fermentation Methods 0.000 claims abstract description 112
- 230000004151 fermentation Effects 0.000 claims abstract description 112
- 239000000052 vinegar Substances 0.000 claims abstract description 52
- 235000021419 vinegar Nutrition 0.000 claims abstract description 52
- 238000004519 manufacturing process Methods 0.000 claims abstract description 26
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 18
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 14
- 239000012362 glacial acetic acid Substances 0.000 claims abstract description 3
- 239000012141 concentrate Substances 0.000 claims description 18
- 238000011081 inoculation Methods 0.000 claims description 9
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 7
- 150000001720 carbohydrates Chemical class 0.000 claims description 7
- 229930091371 Fructose Natural products 0.000 claims description 4
- 239000005715 Fructose Substances 0.000 claims description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- 229930003231 vitamin Natural products 0.000 claims description 3
- 235000013343 vitamin Nutrition 0.000 claims description 3
- 239000011782 vitamin Substances 0.000 claims description 3
- 229940088594 vitamin Drugs 0.000 claims description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 238000011534 incubation Methods 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims 2
- 229910021529 ammonia Inorganic materials 0.000 claims 1
- 239000012895 dilution Substances 0.000 claims 1
- 238000010790 dilution Methods 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 241000894006 Bacteria Species 0.000 abstract description 19
- 230000008569 process Effects 0.000 abstract description 3
- 239000012535 impurity Substances 0.000 abstract description 2
- 239000000287 crude extract Substances 0.000 abstract 1
- 235000010633 broth Nutrition 0.000 description 19
- 235000008504 concentrate Nutrition 0.000 description 19
- 230000000694 effects Effects 0.000 description 19
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- 230000004044 response Effects 0.000 description 10
- 235000000346 sugar Nutrition 0.000 description 10
- 230000002265 prevention Effects 0.000 description 9
- 230000003247 decreasing effect Effects 0.000 description 8
- 235000010208 anthocyanin Nutrition 0.000 description 7
- 229930002877 anthocyanin Natural products 0.000 description 7
- 239000004410 anthocyanin Substances 0.000 description 7
- 150000004636 anthocyanins Chemical class 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 238000005457 optimization Methods 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 150000008442 polyphenolic compounds Chemical class 0.000 description 6
- 235000013824 polyphenols Nutrition 0.000 description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 5
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 5
- 229930003268 Vitamin C Natural products 0.000 description 5
- 229940041514 candida albicans extract Drugs 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 235000019640 taste Nutrition 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 208000019553 vascular disease Diseases 0.000 description 5
- 239000011718 vitamin C Substances 0.000 description 5
- 235000019154 vitamin C Nutrition 0.000 description 5
- 239000012138 yeast extract Substances 0.000 description 5
- 208000014644 Brain disease Diseases 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 230000004438 eyesight Effects 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 230000001953 sensory effect Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 235000011511 Diospyros Nutrition 0.000 description 3
- 244000236655 Diospyros kaki Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 235000009754 Vitis X bourquina Nutrition 0.000 description 3
- 235000012333 Vitis X labruscana Nutrition 0.000 description 3
- 240000006365 Vitis vinifera Species 0.000 description 3
- 235000014787 Vitis vinifera Nutrition 0.000 description 3
- 230000001476 alcoholic effect Effects 0.000 description 3
- 235000021028 berry Nutrition 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000006806 disease prevention Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000012907 honey Nutrition 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 206010013911 Dysgeusia Diseases 0.000 description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 2
- 229920001202 Inulin Polymers 0.000 description 2
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 2
- 235000009827 Prunus armeniaca Nutrition 0.000 description 2
- 244000018633 Prunus armeniaca Species 0.000 description 2
- 235000003434 Sesamum indicum Nutrition 0.000 description 2
- 244000040738 Sesamum orientale Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 240000000851 Vaccinium corymbosum Species 0.000 description 2
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 2
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 235000021014 blueberries Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
- 229960000367 inositol Drugs 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 2
- 229940029339 inulin Drugs 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 238000010993 response surface methodology Methods 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 229940031439 squalene Drugs 0.000 description 2
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000005211 surface analysis Methods 0.000 description 2
- 235000019605 sweet taste sensations Nutrition 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 235000014101 wine Nutrition 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- SEPPVOUBHWNCAW-FNORWQNLSA-N (E)-4-oxonon-2-enal Chemical compound CCCCCC(=O)\C=C\C=O SEPPVOUBHWNCAW-FNORWQNLSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- NCYCYZXNIZJOKI-IOUUIBBYSA-N 11-cis-retinal Chemical compound O=C/C=C(\C)/C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-IOUUIBBYSA-N 0.000 description 1
- HZLCGUXUOFWCCN-UHFFFAOYSA-N 2-hydroxynonadecane-1,2,3-tricarboxylic acid Chemical compound CCCCCCCCCCCCCCCCC(C(O)=O)C(O)(C(O)=O)CC(O)=O HZLCGUXUOFWCCN-UHFFFAOYSA-N 0.000 description 1
- LLBZPESJRQGYMB-UHFFFAOYSA-N 4-one Natural products O1C(C(=O)CC)CC(C)C11C2(C)CCC(C3(C)C(C(C)(CO)C(OC4C(C(O)C(O)C(COC5C(C(O)C(O)CO5)OC5C(C(OC6C(C(O)C(O)C(CO)O6)O)C(O)C(CO)O5)OC5C(C(O)C(O)C(C)O5)O)O4)O)CC3)CC3)=C3C2(C)CC1 LLBZPESJRQGYMB-UHFFFAOYSA-N 0.000 description 1
- TVEXGJYMHHTVKP-UHFFFAOYSA-N 6-oxabicyclo[3.2.1]oct-3-en-7-one Chemical compound C1C2C(=O)OC1C=CC2 TVEXGJYMHHTVKP-UHFFFAOYSA-N 0.000 description 1
- CFKXWTNHIJAFNL-UHFFFAOYSA-N Acacic acid Natural products CC12CCC(O)C(C)(C)C1CCC1(C)C2CC=C2C3CC(C)(C)C(O)CC3(C(O)=O)C(O)CC21C CFKXWTNHIJAFNL-UHFFFAOYSA-N 0.000 description 1
- 235000009434 Actinidia chinensis Nutrition 0.000 description 1
- 244000298697 Actinidia deliciosa Species 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 101100313763 Arabidopsis thaliana TIM22-2 gene Proteins 0.000 description 1
- 241000473391 Archosargus rhomboidalis Species 0.000 description 1
- 241001444061 Aronia x prunifolia Species 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- 244000260524 Chrysanthemum balsamita Species 0.000 description 1
- 235000005633 Chrysanthemum balsamita Nutrition 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 244000119461 Garcinia xanthochymus Species 0.000 description 1
- 235000000885 Garcinia xanthochymus Nutrition 0.000 description 1
- 241000032681 Gluconacetobacter Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920001410 Microfiber Polymers 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 241001396014 Priacanthus arenatus Species 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- 240000007942 Prunus pensylvanica Species 0.000 description 1
- 235000013647 Prunus pensylvanica Nutrition 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 235000014441 Prunus serotina Nutrition 0.000 description 1
- 241000508269 Psidium Species 0.000 description 1
- 102000004330 Rhodopsin Human genes 0.000 description 1
- 108090000820 Rhodopsin Proteins 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 241001412173 Rubus canescens Species 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- PZDZHSVBBNQZGU-UHFFFAOYSA-N [Ar].CCO Chemical compound [Ar].CCO PZDZHSVBBNQZGU-UHFFFAOYSA-N 0.000 description 1
- YBCVMFKXIKNREZ-UHFFFAOYSA-N acoh acetic acid Chemical compound CC(O)=O.CC(O)=O YBCVMFKXIKNREZ-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 229940040563 agaric acid Drugs 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 229910052614 beryl Inorganic materials 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 229910052956 cinnabar Inorganic materials 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000010219 correlation analysis Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 235000021185 dessert Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000037228 dieting effect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 239000000576 food coloring agent Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- 235000008960 ketchup Nutrition 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 239000003658 microfiber Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 238000013433 optimization analysis Methods 0.000 description 1
- 238000012261 overproduction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000000611 regression analysis Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 235000013322 soy milk Nutrition 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 229940126672 traditional medicines Drugs 0.000 description 1
- 229940074410 trehalose Drugs 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 238000004383 yellowing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12J—VINEGAR; PREPARATION OR PURIFICATION THEREOF
- C12J1/00—Vinegar; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/09—Mashed or comminuted products, e.g. pulp, purée, sauce, or products made therefrom, e.g. snacks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/38—Other non-alcoholic beverages
- A23L2/382—Other non-alcoholic beverages fermented
Landscapes
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
Abstract
본 발명은 아로니아를 이용한 식초의 제조방법 및 이를 이용한 식초음료에 관한 것이다. 보다 상세하게는 아로니아 열매로부터 이물을 제거하여 파쇄 및 착즙한 후, 아로니아 착즙액을 얻는 단계와, 아로니아 착즙액에 당류를 사용하여 26∼29°bx로 보당한 후, 팩틴분해효소와 알콜발효 효모를 0.002~2%를 첨가하고 24∼26℃에서 7∼9일간 배양하여 여과한 후 12∼14v% 아로니아 에탄올 발효 단계와, 아로니아 에탄올 발효액을 3∼9%로 조절하고 빙초산으로 초산 농도 1∼2v%로 산도를 조정한 후 초산균을 접종하여 28∼32℃에서 13∼15일간 배양하는 초산발효 단계로 구성된다.
본 발명의 아로니아 초산 발효는 초기 에탄올과 초산이 적정 농도 이상으로 함유되어 있어야 초산균이 활성화 되어 원활한 초산 발효가 일어난다.The present invention relates to a process for producing vinegar using aronia and a vinegar drink using the same. More particularly, the present invention relates to a method for producing a crude extract of Aronia, comprising the steps of removing impurities from the Aronia fruit, crushing and juicing it, obtaining an Aronia juice, After fermentation, fermentation of 12 ~ 14v% ethanol and fermentation of aroniae ethanol was performed at 3 ~ 9% and glacial acetic acid was added. And an acetic acid fermentation step in which acetic acid is inoculated with acetic acid at a concentration of 1 to 2% by volume and then incubated at 28 to 32 ° C for 13 to 15 days.
In the fermentation of the present invention, the initial ethanol and acetic acid should be contained at an appropriate concentration or higher so that acetic acid bacteria are activated and smooth acetic acid fermentation takes place.
Description
본 발명은 아로니아를 이용한 식초의 제조방법 및 이를 이용한 식초음료에 관한 것이다. 보다 상세하게는 아로니아 열매로부터 이물을 제거하여 파쇄 및 착즙한 후, 아로니아 착즙액을 얻는 단계와, 아로니아 착즙액에 당류로 보당한 후, 팩틴분해효소와 알콜발효 효모를 첨가하고 배양하여 여과한 후 아로니아 에탄올 발효하는 단계와, 아로니아 에탄올 발효액을 희석하여 농도를 조절하고 초산 농도를 조정한 후 초산균을 접종하여 배양하는 초산발효 단계로 구성된다. 또한 아로니아 식초에 여러가지 부형제를 첨가하여 식초음료를 제공한다.The present invention relates to a process for producing vinegar using aronia and a vinegar drink using the same. More particularly, the present invention relates to a method for producing a yeast extract, which comprises the steps of removing foreign matter from the Aronia fruit, crushing and juicing it, obtaining an Aronia juice solution, saccharizing the Aronia juice, adding a pectin degrading enzyme and an alcohol fermentation yeast, Fermenting the fermentation with aronia ethanol after filtration, adjusting the concentration of acornic acid by diluting the fermentation broth of aronia ethanol, adjusting the acetic acid concentration, and inoculating the acetic acid bacteria. In addition, vinegar drinks are provided by adding various excipients to Aronia vinegar.
본 발명의 아로니아 식초는 기능성 성분인 안토시아닌과 폴리페놀이 함유되어 있어 항산화 효과, 시력회복 효과, 혈관질환 예방 효과, 뇌질환의 예방과 치료 효과, 당뇨 예방 효과, 면역력 증진 효과, 다이어트 효과 등이 있으므로 건강 음료로 제공될 수 있다.The vinegar of the present invention contains an anthocyanin and a polyphenol which are functional ingredients, and can be used for antioxidant effect, vision recovery effect, vascular disease prevention effect, prevention and treatment effect of brain disease, diabetes prevention effect, immunity enhancement effect, Therefore, it can be provided as a health drink.
아로니아(aronia)는 장미과의 다년생 관목으로 북아메리카의 동북부 지역이 원산이며, 그 열매와 잎 등을 인디언들과 초기 이민 정착인들이 전통약재로 활용했다고 한다. 1930년대 러시아의 식물학자 이반 미츄린 교수에 의해 열매의 맛과 향이 좋아 과즙을 음료로 사용하기 시작했으며, 본격적으로 재배되기 시작한 것은 1978년 폴란드가 러시아에서 도입해 상업적으로 재배되면서 부터이다. 최근 우리나라에도 폴란드산 원액이 수입되어 국내 제품과 경쟁하고 있으며, 고창군, 단양군 등에서 많은 재배가 이루어져 소비가 시급한 실정이다. Aronia is a perennial shrub of Rosaceae that is native to North-East of North America and its fruits and leaves have been used as traditional medicines by Indians and early immigrant settlers. In the 1930s, a botanist of Russia, Ivan Mikurin, began using fruit juice as a drink because of its good taste and flavor. It was cultivated in 1978 when Poland was introduced in Russia and cultivated commercially. Recently, Korea has also been importing polish stocks and competing with domestic products. Many cultivations have been made in Gochang-gun, Danyang-gun, etc., and consumption is urgent.
아로니아는 레드 초크베리, 블랙 초크베리, 퍼플 초크베리의 3가지를 합쳐서 아로니아라고 하며 킹스베리(King's Berry)로도 불린다. 아로니아 나무의 열매는 식용, 식용색소, 약용, 관상용으로도 재배된다. 아로니아는 안토시아닌의 함량이 블루베리의 4-5배 이상으로 높아서 강력한 황산화물질이 들어 있으며, 폴리페놀도 포도의 80배, 복분자의 20배, 크린베리의 13배로서 건강기능성 물질을 다량 함유하고 있다. 안토시아닌과 폴리페놀은 활성산소를 중화시키는 항산화 효과, 로돕신의 재합성을 촉진하는 시력회복 효과, 혈관의 콜레스테롤을 억제하여 혈관질환을 예방하는 효과, 카테킨과 상호작용으로 각종 뇌질환의 예방과 치료 효과, 인슐린 생성을 향상시켜 당뇨 에방 효과, 백혈구의 생성을 촉진시켜 면역력을 증진시키는 효과, 체지방을 분해하여 다이어트 효과 등이 있다고 알려져 있다. Aronia is called Aronia and King's Berry, which is a combination of three red cherry berry, black cherry berry and purple chokeberry. Fruits of Aronia trees are also grown for edible, food coloring, medicinal and ornamental use. Aronia has anthocyanin content of more than 4-5 times higher than blueberries, and contains strong sulfated substances. Polyphenols also contain a large amount of health functional substances, such as 80 times of grape, 20 times of bokbunja, and 13 times of cinnabar . Anthocyanin and polyphenol have antioxidative effects that neutralize active oxygen, the effect of restoring visual acuity to promote rearrangement of rhodopsin, the effect of inhibiting blood vessels by inhibiting cholesterol and preventing vascular diseases, and the prevention and treatment of various brain diseases through interaction with catechins , It is known that diabetic effect by enhancing insulin production, effect of stimulating the production of white blood cells by enhancing the immunity, and dieting effect by decomposing body fat.
한편 아로니아에 관련된 종래기술로는 한국특허등록번호 1013832760000(아로니아 음료 농축액 및 그 제조방법)은 아로니아 열매를 제분기에 넣고 분쇄하고 1차 효소를 넣고 45~60 ℃ 범위에서 1~2시간 범위로 예열하는 공정과 상기의 예열물을 압착시켜 여액을 얻되, 10~50메쉬 범위의 체를 통하여 예열물을 압착하여 찌거기를 분리하고 여액을 얻는 공정과 상기 여액에 2차 효소를 넣고 45~60 ℃ 범위에서 1~2시간 범위로 숙성시키는 공정과 상기 숙성물에 천연식물 중에서 선택되는 정화제를 넣고 부유성분을 침전시키고 여과하는 공정을 통하여 60~75 brix 범위의 농도를 갖는 아로니아 음료 농축액을 얻고, 상기 아로니아 농축액이 1~10 wt% 범위로 함유되고, 구연산나트륨, 사과산, 이산화규소, 향료 중에서 하나 이상 선택되는 식용첨가제가 1~5 wt% 범위로 포함된 후 당류가 잔량을 이루어 음료용 프리믹스 원료로 제공되는 아로니아 음료에 관한 것이다. Korean Patent Registration No. 1013832760000 (Arrioni beverage concentrate and its preparation method) related to Aronia is a method in which Aronia fruit is pulverized in a mill, added with a primary enzyme and heated at 45 to 60 ° C for 1 to 2 hours And the preheated material is compressed to obtain a filtrate. The preheated material is squeezed through a sieve having a size in the range of 10 to 50 mesh to separate the debris and obtain a filtrate. A second enzyme is added to the filtrate, 60 ° C for 1 to 2 hours, adding a cleaning agent selected from natural plants to the aged material, precipitating the suspended components, and filtering the agaric acid beverage concentrate having a concentration ranging from 60 to 75 brix And 1 to 5 wt% of an edible additive selected from at least one of sodium citrate, malic acid, silicon dioxide and fragrance is contained in an amount of 1 to 10 wt% Oh relates to Catalonia beverage flow is provided to premix ingredients made for the remaining drinks.
한국특허등록번호 1011630720000(아로니아 열매 추출물의 정제 및 분말화 방법)은 아로니아 열매의 추출원액에 대해 칼럼 크로마토그래피를 실시하되, Diaion HP20 수지를 흡착수지로 사용하고, 황산이나 구연산에 의해 산성화된 에탄올을 세척용매로 사용함으로써, 지표물질인 안토시아닌의 함량이 높고, 처리비용이 저렴한 아로니아 열매 추출물의 정제방법과 이러한 방법으로 수득된 정제물을 분말화 하는 방법에 관한 것이다.Korean Patent Registration No. 1011630720000 (refining and powdering method of Aronia fruit extract) is a method of conducting column chromatography on raw extract of Aronia fruit, using Diaion HP20 resin as an adsorbent resin, and acidifying with sulfuric acid or citric acid The present invention relates to a method for purifying an extract of Aronia fruit which has a high content of anthocyanin as an indicator substance and low in processing cost by using ethanol as a washing solvent and a method for pulverizing the purified product obtained by this method.
일본공개특허 제 2009-065889A호(제떫은 맛 성분 함유 과실 식품의 떫은 맛 제거 및 제조방법)는 탈삽방법으로 감, 아로니아등의 미탈삽의 떫은맛 성분 함유시켜 과실을 페이스트형에 가공하고, 그 페이스트에 가식성 단백질로서 두유, 우유, 생크림, 쇼즈, 다이즈, 어패류의 으깬 어묵의 1종 또는 2종 이상을 첨가한다.또한 떫은맛 성분 함유 과실 식품의 제조 방법은 가식성 단백질로서 두유, 우유, 생크림, 쇼즈, 다이즈, 어패류의 으깬 어묵의 1종 또는 2종 이상을 첨가해 탈삽 한 감, 아로니아등의 떫은맛 성분 함유 과실의 페이스트를 다른 임의의 식품 소재와 혼합하고, 혼합 된 임의의 식품 소재를 가열한다.Japanese Patent Application Laid-Open No. 2009-065889A (a method for removing and producing a tasty taste of fruit foods containing a flavor ingredient) is a method of adding a sweet taste component of micas to flavor and aroma, The paste is added with one or more kinds of edible proteins such as soy milk, milk, cream, shoeze, daisies, and crushed sesame seeds of fish and shellfish. The pasta paste containing the sweet taste component such as fresh persimmon, shoeze, dessert, crushed sesame cake of persimmon and sea bream added with at least one kind of persimmon or astringent is mixed with any other food material, Heat the material.
한국특허등록번호 1013825940000(복분자 식초음료 조성물 및 이의 제조방법)은 정제수 100중량부에 대하여 복분자 식초 1∼5중량부, 복분자착즙액 0.1∼1중량부, 구연산 0.05∼0.2중량부, 비타민 0.01∼0.1중량부, 가르시니아캄보지아추출물 0.1∼1중량부, 과일농축액 1∼10중량부, 당류 5∼10중량부, 쥐눈이콩 분말 0.1∼1중량부를 첨가하고 혼합하는 단계를 포함하는 복분자 식초음료 조성물의 제조방법이다. Korean Patent Registration No. 1013825940000 (Bokbunja vinegar beverage composition and its preparation method) is characterized in that 1 to 5 parts by weight of bokbunja vinegar, 0.1 to 1 part by weight of bokbunja juice, 0.05 to 0.2 parts by weight of citric acid, 0.01 to 0.1 part by weight of vitamins , 0.1 to 1 part by weight of an extract of Garcinia cambogia, 1 to 10 parts by weight of a fruit concentrate, 5 to 10 parts by weight of a saccharide, and 0.1 to 1 part by weight of a soybean powder of a big eye are added and mixed. to be.
한국특허공개번호1020120122175(식초음료의 제조방법)은 발효식초 11~13중량%, 농축과즙 8~11중량%, 설탕 6~8중량%, 벌꿀 1~2중량%, 레몬즙 0.1~1중량%를 배합하여 정제수 68~73중량%d의 배합 단계; 활성탄과 극세사를 이용해 여과하는 단계; 무균시설에서 규격용기에 투입, 밀봉, 이물질 혼입여부 검사, 서늘한 창고에 보관 후 출하 단계로 구성된다.Korean Patent Laid-open Publication No. 1020120122175 discloses a method for producing vinegar beverage comprising 11 to 13 wt% of fermented vinegar, 8 to 11 wt% of concentrated juice, 6 to 8 wt% of sugar, 1 to 2 wt% of honey, To prepare 68 to 73% by weight of purified water; Filtration using activated carbon and microfibers; It is made up of sterilized facilities in standard containers for sealing, inspecting for contamination, storage in a cool warehouse and shipping stage.
그러나 이들 종래기술은 본 발명과 기술적구성이 다른 것이다.However, these prior arts have different technical constructions from those of the present invention.
최근 농가에서 특용작물로 아로니아가 대량으로 생산되고 있지만, 과잉생산에 따라 수요처를 찾지 못하여 농가의 부담이 가중되고 있다. 더욱이 이들의 우수한 기능성 성분을 상품화시키지 못하여 자원의 낭비가 우려된다. 그러나 아로니아에는 기능성 성분인 안토시아닌과 폴리페놀이 함유되어 있어 항산화, 시력회복, 혈관질환 예방, 당뇨 예방, 면역력 증진, 다이어트 등에 효과가 있으나 마땅한 가공식품으로 개발되지 못하고 있다.In recent years, Aronia has been produced in large quantities as a special crop in farmhouses, but due to overproduction, farmers have been burdened by the lack of demand. Further, these excellent functional components can not be commercialized, and waste of resources is a concern. However, Aronia contains anthocyanins and polyphenols as functional ingredients, which are effective for antioxidation, vision recovery, prevention of vascular diseases, prevention of diabetes, improvement of immunity, and diet.
본 발명은 아로니아를 이용한 식초의 제조방법 및 이를 이용한 식초음료에 관한 것이다. 아로니아 열매로부터 이물을 제거하여 파쇄 및 착즙한 후, 아로니아 착즙액을 얻는 단계와, 아로니아 착즙액에 당류를 사용하여 26∼29°bx로 보당한 후, 에탄올 발효에 팩틴분해효소 및 알콜발효 효모 ?∼?%를 첨가하고 24∼26℃에서 7∼9일간 배양하여 여과한 후 12∼14v% 아로니아 에탄올 발효 단계와, 아로니아 에탄올 발효액을 3∼9%로 조절하고 빙초산으로 초산 농도 1∼2v%로 산도를 조정한 후 초산균을 접종하여 28∼32℃에서 13∼15일간 배양하는 초산발효 단계로 구성된다. 또한 아로니아 식초에 여러가지 부형제를 첨가하여 식초음료를 제공한다.The present invention relates to a process for producing vinegar using aronia and a vinegar drink using the same. Removing the foreign matter from the Aronia fruit, crushing and juicing it, obtaining an Aronia juice solution, and, after sacrificing the Aronia juice by using a saccharide at 26 to 29 ° bx, After fermentation, fermentation was carried out at 24 ~ 26 ℃ for 7 ~ 9 days. After filtration, 12 ~ 14v% ethanolic fermentation with argon ethanol and 3 ~ 9% ethanolic fermentation with acetic acid And an acetic acid fermentation step in which the acidity is adjusted to 1 to 2% by volume, and the acetic acid bacteria are inoculated and cultured at 28 to 32 ° C for 13 to 15 days. In addition, vinegar drinks are provided by adding various excipients to Aronia vinegar.
본 발명의 아로니아 식초는 기능성 성분인 안토시아닌과 폴리페놀이 함유되어 있어 항산화 효과, 시력회복 효과, 혈관질환 예방 효과, 뇌질환의 예방과 치료 효과, 당뇨 예방 효과, 면역력 증진 효과, 다이어트 효과 등이 있으므로 건강 음료로 제공될 수 있다.The vinegar of the present invention contains an anthocyanin and a polyphenol which are functional ingredients, and can be used for antioxidant effect, vision recovery effect, vascular disease prevention effect, prevention and treatment effect of brain disease, diabetes prevention effect, immunity enhancement effect, Therefore, it can be provided as a health drink.
도 1은 초산 발효 조건 중 당도 변화를 나타낸 것이다.
도 2는 초산 발효 조건 중 산도 변화를 나타낸 것이다.
도 3은 초산 발효 조건 중 알콜 변화를 나타낸 것이다.
도 4는 초산발효 조건 중 pH변화를 나타낸 것이다.
도 5는 식초발효의 최적화를 위한 섭동 계획과 표면 반응을 나타낸 것이다. 도 6은 아로니아 식초 발효의 바람직한 최적화를 위한 섭동 계획과 표면 반응을 나타낸 것이다.
도 7은 식초발효의 최적화를 위한 일반 영역과 오버레이 계획을 나타낸 것이다. Figure 1 shows the change in sugar content during the acetic acid fermentation conditions.
Fig. 2 shows changes in acidity during acetic acid fermentation conditions.
Figure 3 shows changes in alcohol during acetic acid fermentation conditions.
Fig. 4 shows the change in pH during acetic acid fermentation conditions.
Figure 5 shows the perturbation plan and surface response for optimization of vinegar fermentation. Figure 6 shows the perturbation plan and surface response for the preferred optimization of the Aronia vinegar fermentation.
Figure 7 shows the general area and overlay scheme for optimizing vinegar fermentation.
본 발명은 아로니아 열매로부터 이물을 제거하여 파쇄 및 착즙하여 아로니아 착즙액을 얻는 단계와, 아로니아 착즙액에 당류로 보당한 후, 팩틴분해효소와 알콜발효 효모를 첨가하고 배양하여 여과한 후 아로니아 에탄올 발효하는 단계와, 아로니아 에탄올 발효액을 희석하여 농도를 조절하고 초산 농도 조정한 후 초산균을 접종하여 배양하는 초산발효 단계로 구성된다. 또한 아로니아 식초에 여러가지 부형제를 첨가하여 식초음료를 제공한다.The present invention relates to a method for producing a yeast extract, which comprises the steps of removing impurities from an Aronia fruit to obtain an Aronia juice by crushing and squeezing the juice, and then adding a saccharide to the Aronia juice, adding a paclitolase and an alcohol fermentation yeast, Fermentation of ethanolic fermentation with Aronia, and acetic acid fermentation step in which fermentation of Aronia ethanol fermentation solution is diluted, concentration is adjusted, acetic acid concentration is adjusted, and acetic acid bacteria are inoculated and cultured. In addition, vinegar drinks are provided by adding various excipients to Aronia vinegar.
<실험 재료> <Materials>
아로니아는 전라북도 고창군에서 재배된 열매를 농가로부터 구입하여 냉동보관하면서 사용하였다. 에탄올 발효에 팩틴분해효소 (Pectinex ultra clear, Novozymes, Denmark)를 첨가하고, 사용된 효모(Saccharomyces cerevisiae)는 시판 효모인 Fermivin(Fredericia, Denmark)을 사용하였고, 초산 발효를 위한 초산균은 농촌진흥청에서 Gluconoacetobacter inermedius CV2를 분양받아 사용하였다. 초산균 배양을 위한 배지 제조시 사용된 yeast extract, peptone, agar는 BD Difco(Becton, Dickinson & Co., Paris, France)에서, 이를 제외한 모든 시약은 Sigma-Aldrich(St Louis, MO, USA)에서 구입하여 사용하였다. Aronia was purchased from a farmhouse and used for frozen storage. Pectinol ultra clear (Novozymes, Denmark) was added to the ethanol fermentation and the yeast used ( Saccharomyces cerevisiae) was used as the commercially available yeast Fermivin (Fredericia, Denmark), chosangyun for acetic acid fermentation was used under the pre-sale Gluconoacetobacter inermedius CV2 in the RDA. All reagents except for the yeast extract, peptone and agar used in the preparation of the culture medium for the cultivation of acetic acid bacteria were purchased from BD Difco (Becton, Dickinson & Co., Paris, France) and purchased from Sigma-Aldrich Respectively.
<실시예 1>; 에탄올 발효 ≪ Example 1 > Ethanol fermentation
아로니아 식초원료로 사용하기 위해 아로니아 열매를 착즙하여 알코올 발효를 실시하였다. 아로니아 열매를 파쇄한 후 액상과당을 사용하여 28 °bx가 되도록 보당하고 팩틴분해효소를 첨가하고, 시판 효모로 25℃에서 8일간 발효시킨 후 여과한 여액을 초산 발효 기질로 사용하였다. 알코올 발효 종료는 알코올 함량과 환원당 함량을 측정하여 확인하였다.For use as raw material of Aronia vinegar, Aronia fruit was juiced and alcohol fermentation was carried out. Fructose degradation enzyme was added to the fermented broth, which was fermented at 25 ℃ for 8 days. Then, the filtrate was used as acetic acid fermentation substrate. The alcohol fermentation termination was confirmed by measuring alcohol content and reducing sugar content.
아로니아 착즙액을 8일간 알코올 발효 시키면서 발효 과정중 당도와 알코올 등 함량의 변화를 측정한 결과는 표 1과 같았다.Table 1 shows the changes in sugar content and alcohol content during fermentation of alcoholic fermentation of Aronia juice for 8 days.
알코올 발효가 진행됨에 따라 환원당은 감소하면서 알코올이 생성되는 것을 확인하였다. 환원당은 3일 이후로 급격히 감소하여 7일 이후 4~5%에 도달하였고, 알코올 함량은 3일 이후 급격히 증가하여 최종적으로 13.1%의 아로니아 알코올 발효액이 생성되었다. As alcohol fermentation progressed, reducing sugar decreased and alcohol was produced. Reducing sugar decreased rapidly after 3 days, reaching 4 ~ 5% after 7 days. Alcohol content increased rapidly after 3 days and finally 13.1% of the fermentation broth was produced.
<실시예 2>; 배지 및 초산 발효≪ Example 2 > Medium and acetic acid fermentation
아로니아 와인의 초산 발효를 위한 초산균의 고체배지 조성은 glucose 0.5%, yeast extract 0.5%, Glycerin 1.0%, MgSO4H2O 0.02%, ethanol 5%, acetic acid 1%, agar 2.0%였으며, 초산균 액체 배지 조성은 glucose 0.5%, yeast extract 0.5%, glycerin 1.0%, MgSO47H2O 0.02%이었으며 배양온도는 30℃이었다.For the acetic acid fermentation of Aronia wines, acetic acid was 0.5% glucose, 0.5% yeast extract, 1.0% glycerin, 0.02% MgSO 4 H 2 O, 5% ethanol, acetic acid and 2.0% agar. The composition of liquid medium was 0.5% glucose, 0.5% yeast extract, 1.0% glycerin, 0.02% MgSO 4 7H 2 O and the incubation temperature was 30 ℃.
<초산발효><Acetic acid fermentation>
아로니아 초산 발효를 위해 아로니아 알코올 발효액을 일정 농도로 희석하고 빙초산으로 초기 산도를 조정한 후 초산균을 접종하여 30℃에서 14일간 발효시키면서 특성 조사를 실시하였다. 예비실험을 통해 최소 및 최대 범위를 각각 아로니아 알코올 발효액의 초기 알코올 함량은 3~9%, 초기 초산 농도는 0.3~1.9%, 초산균 접종량은 5~20%로 정하였다. 초산 발효를 위한 알코올 농도, 초기 초산 농도, 초산균 농도 조건을 알기 위해 표 2와 같이 3 요인 계획을 수립하였다. For the fermentation of arnoic acid, fermentation of Aronia alcohol was diluted to a certain concentration, initial acidity was adjusted with glacial acetic acid, and then acetic acid bacteria were inoculated and fermented at 30 ℃ for 14 days. The initial and final concentrations of alcoholic fermentation broth were 3 ~ 9%, 0.3 ~ 1.9%, and 5 ~ 20%, respectively. To determine the alcohol concentration, initial acetic acid concentration, and acetic acid bacteria concentration condition for acetic acid fermentation, a three factor plan was established as shown in Table 2.
<특성조사> <Investigation of characteristics>
아로니아 알코올 발효액과 초산 발효액의 발효 특성을 알아보기 위해 초산 생성량, 잔류 알코올 함량, pH, 색도를 측정하였다. 발효조건에 따른 아로니아 식초의 초산 생성량은 0.1 N NaOH를 이용하여 초산 발효액을 중화적정한 후 acetic acid를 측정한 후 초기 초산 농도를 빼고 초산 생성량을 계산하였다. 알코올 함량은 발효액을 15,000 rpm에서 15분간 원심분리하여 균체를 제거한 후 상징액을 알코올 분석기 (Alcolyzer Wine, Anton Paar, Austria)를 이용하여 측정하였다. 초산 발효액의 pH는 pH meter (Seveneasy, Mettler-Toledo, Switzerland)를 사용하여 측정하였다. 색도는 분광색차계(CM-5, Konica Minolta, Japan)를 사용하여 L, a, b 값을 측정하였다.Acetic acid production, residual alcohol content, pH and color were measured to investigate the fermentation characteristics of the fermentation broth of acorn alcohol and acetic acid. Acetic acid production was determined by neutralization of acetic acid fermentation broth with 0.1 N NaOH according to the fermentation conditions. The acetic acid was measured and the acetic acid production was calculated by subtracting the initial acetic acid concentration. The alcohol content was determined by centrifuging the fermentation broth at 15,000 rpm for 15 minutes, removing the cells, and measuring the supernatant using an alcohol analyzer (Alcolyzer Wine, Anton Paar, Austria). The pH of the acetic acid fermentation broth was measured using a pH meter (Seveneasy, Mettler-Toledo, Switzerland). L, a, and b values were measured using a spectral colorimeter (CM-5, Konica Minolta, Japan).
<통계처리><Statistics Processing>
아로니아 식초의 초산발효 실험 계획, 분석, 최적화 분석은 Design Expert 9(Stat-Easy Co., Minneapolis, MN, USA) 프로그램을 사용하여, 반응표면 실험계획법(Response surface methodology)의 중심합성디자인에 따라 설계하였다. 초산 발효에 영향을 미칠 수 있는 발효 조건(초기 알코올 함량, 초기 초산 농도, 초산균 접종량)을 각각 독립변수로 하고 실험결과인 초산 생성량, 잔류 알코올 함량, pH, 색도는 반응변수로 설정하였다. 아로니아 식초의 발효 최적조건을 알아보기 위해 ANOVA test 및 회귀분석을 이용하였으며 model의 적합성 여부는 F-test로 유의성을 검증하였고, 변수들 사이의 상관관계분석을 실시하였다. 각 성분들의 반응을 보기 위해서는 pertubation plot와 response surface 3D plot을 이용하였다. The plan, analysis and optimization analysis of acorn fermentation of Aronia vinegar was carried out according to the central synthesis design of Response surface methodology using Design Expert 9 (Stat-Easy Co., Minneapolis, MN, USA) Respectively. The fermentation conditions (initial alcohol content, initial acetic acid concentration, inoculation amount of acetic acid bacteria) that could affect acetic acid fermentation were independent variables. Acetic acid production, residual alcohol content, pH and chromaticity were determined as response variables. ANOVA test and regression analysis were used to determine the optimal fermentation conditions of Aronia vinegar. The suitability of the model was verified as F- test and the correlation analysis was performed between the variables. The pertubation plot and the response surface 3D plot were used to see the response of each component.
모형의 최적화는 각 반응에 대한 최소 혹은 최대 제한점을 결정하여 입력하였을 때 가능한 범위에서 그래프가 중첩되는 부분으로 구하였다.The optimization of the model was obtained by determining the minimum or maximum limit for each reaction and the overlapping of the graphs as much as possible when entered.
초산발효 결과는 도 1 ~ 도 4에 나타내었다. 분석결과 산도는 조건별로 초산생성이 차이가 나기는 하지만 시간이 경과할수록 초산이 생성되었고, 알콜은 감소하는 경향을 보였다. pH는 초산생성에 의해 낮아지는 경향을 나타냈다. The results of the acetic acid fermentation are shown in FIG. 1 to FIG. As a result, acetic acid was produced and acetic acid was decreased with time. The pH tended to be lowered by acetic acid production.
<중심합성 계획법에 의한 초산발효 최적조건><Optimum Conditions for Acetic Acid Fermentation by Central Synthesis Scheme>
아로니아 알코올 발효액의 초산발효 최적 조건을 찾기 위해 중심합성 실험계획법에 의하여 발효조건이 다른 16개 실험구와 그것에 따른 아로니아 식초의 특성조사를 실시하였고, 결과는 표 3과 같았다. 초산 생성량, 잔류 알코올 함량, pH, 색도(L, a, b)는 반응표면 분석의 결과 R2가 0.92~0.99로 높은 편이었으며 p value 결과가 1% 미만으로 모두 유의성이 인정되었다(표 4). 보였다. To investigate the optimum conditions of acetic acid fermentation of Aronia alcohol fermentation broth, 16 specimens with different fermentation conditions were investigated by central synthetic design method and the characteristics of Aronia vinegar were investigated. The results of the reaction surface analysis showed that R 2 was 0.92 ~ 0.99 and the p value was less than 1% (Table 4) . It looked.
1) 초산 생성량1) Acetic acid production
발효 조건이 다른 16개의 알코올 발효액을 14일간 초산 발효 후 산도를 측정하고 초기 초산농도를 고려하여 초산 생성량을 계산한 결과 초산 수율이 26.34∼57.82 g/L이었다(표 2).The acidity of the fermentation broth of 16 different alcoholic fermentation broths was measured after 14 days fermentation and the acetic acid yield was calculated to be 26.34 ~ 57.82 g / L (Table 2).
1): Coded variables 1) : Coded variables
2): Y1=acetic acid yield, Y2= residual alcohol content, Y3=pH, Y4=L, Y5=a, Y6=b 2): Y 1 = acetic acid yield, Y 2 = residual alcohol content, Y 3 = pH, Y 4 = L,
초산 생성량은 각각의 독립 변수 간에 교호작용하는 quadratic 모델이 선정되었고, R2 값은 0.9859로 모델의 적합성이 인정되었으며, p value는 <0.0001으로 유의적인 차이를 나타냈다(표 4).The quatratic model was chosen for each of the independent variables. The R 2 value was 0.9859, and the p value was <0.0001, indicating a significant difference (Table 4).
수율Acetic acid
yield
알콩농도Residue
Alkong concentration
도 5에서와 같이 pertubation plot과 반응표면곡선을 보면 아로니아 알코올 농도와 초기 초산 함량이 높을수록 최종 초산 농도가 증가하였다. 초산 생성량의 최적점은 아로니아 알코올 농도 7.70%, 초산 농도 1.56%, 초산균 접종량 19.87%일 때였으며, 초산 생성량은 57.87mg/L로 예측되었다. As shown in FIG. 5, when the perovskite plot and the reaction surface curve are plotted, the final acetic acid concentration increases as the concentration of aronia alcohol and acetic acid content increases. The optimum point of acetic acid production was at 7.70% of Aronia alcohol concentration, 1.56% of acetic acid concentration and 19.87% of inoculation rate of acetic acid bacteria. Acetic acid production was estimated to be 57.87mg / L.
알코올은 초산균의 영양원이자 발효기질로 초산발효에 영향을 주는 중요한 조건 중 하나이며 본 연구에서는 아로니아 알코올 발효액의 알코올 농도를 3∼9%로 조절하여 초산발효를 진행한 결과 7.70%일 때 최적조건으로 예측되었다. 초기 초산 농도는 0.3∼1.9%로 조절하여 아로니아의 초산 발효를 진행한 결과 초기 초산 농도 1.56%일 때 최적 조건으로 예측하였다.Alcohol is one of the important conditions that affect the fermentation of acetic acid as a nutrient source and fermentation substrate of acetic acid. In this study, the alcohol concentration in the fermentation broth of acaronyl alcohol was adjusted to 3 ~ 9% Respectively. Initial acetic acid concentration was adjusted to 0.3 ~ 1.9%, and it was predicted that the initial acetic acid concentration was 1.56%.
<잔류 알코올 함량><Residual Alcohol Content>
초산 발효 과정 중 알코올을 초산균의 영양원과 발효기질로 사용되므로 발효 후 잔류된 알코올은 발효에 이용되지 않은 것이라 할 수 있다. 16개 실험구의 초산발효 종료 후 잔류 알코올 농도를 측정한 결과 표 3과 같이 0.80∼1.53%였다. 잔류 알코올 농도는 각 요인들이 독립적으로 작용하는 linear 모델이 선정되었고, R2 값은 0.9634로 모델의 적합성이 인정되었으며, p value는 <0.0001으로 유의적인 차이를 나타냈다(표 3). 도 5의 pertubation plot과 반응표면곡선을 보면 발호초기 알코올 함량과 초기 초산농도가 높을수록 잔류 알코올 함량이 감소하였으며, 잔류 알코올 함량을 최소로 하는 최적 조건은 초기 아로니아 알코올 농도 7.78%, 초기 초산농도 1.58%, 초산균 접종량 20.94%였으며 이때 잔류 알코올 함량은 0.76%로 예측되었다. 이론상 초산 발효는 1분자의 알코올로부터 1분자의 초산이 생성되고 1.0 L의 알코올은 약 1.0 kg의 초산이 생성되어야 하나 본 연구 결과 초산 생성량에 비해 발효 후 잔류된 알코올 함량이 적었다.Since alcohol is used as a nutrient source and fermentation substrate of acetic acid during the fermentation of acetic acid, residual alcohol after fermentation is not used for fermentation. The residual alcohol concentration after the completion of acetic acid fermentation in 16 experimental groups was 0.80 to 1.53% as shown in Table 3. The residual alcohol concentration was determined by a linear model in which each factor worked independently. The R 2 value was 0.9634 and the p value was <0.0001, indicating a significant difference (Table 3). In the pertubation plot and the reaction curve of FIG. 5, the residual alcohol content decreased as the initial alcohol concentration and the initial acetic acid concentration increased. The optimum conditions for minimizing the residual alcohol content were 7.78% of the initial alcohol concentration and the initial acetic acid concentration 1.58%, and the inoculation rate of the bacteria was 20.94%. The residual alcohol content was estimated to be 0.76%. Theoretically, the acetic acid fermentation requires one molecule of acetic acid to be produced from one molecule of alcohol and 1.0 kg of acetic acid to produce 1.0 kg of alcohol. However, the amount of alcohol remaining after fermentation is smaller than that of acetic acid.
<pH><pH>
초산 발효 과정동안 생성된 초산에 의해 아로니아 식초의 pH는 점차 감소되었다. 초산 발효 조건이 다른 16개 실험구의 pH를 측정한 결과는 표 3과 같이 3.19∼3.43이었다. 초산발효액의 pH는 각 요인들이 독립적으로 작용하는 linear 모델이 선정되었고, R2 값은 0.9189로 모델의 적합성이 인정되었으며, p value는 <0.0001으로 유의적인 차이를 나타냈다(Table 4). Fig. 6의 pertubation plot과 반응표면곡선을 보면 초기 아로니아 알코올 함량이 높을수록 pH는 증가하고 초기 초산농도가 높을수록 pH는 감소하였다. 아로니아 식초의 pH는 초산 생성에 따라 감소하는 경향은 있으나 비례적으로 감소하지는 않았으며 초산 생성량이 더 높은 시료에서 pH가 더 높게 나타난 경우도 있었다. The pH of Aronia vinegar was gradually decreased by acetic acid produced during acetic acid fermentation. The pH of 16 experimental groups with different acetic acid fermentation conditions was 3.19 ~ 3.43 as shown in Table 3. The pH value of the acetic acid fermentation broth was independently selected by the linear model. The R 2 value was 0.9189 and the p value was <0.0001 (Table 4). Fig. In the pertubation plot and reaction surface curves, pH increased as the initial AAR content increased, and pH decreased as the initial acetic acid concentration increased. The pH of Aronia vinegar tended to decrease with the formation of acetic acid but did not decrease proportionally. In some cases, the pH was higher in the samples with higher acetic acid production.
<색도> <Chromaticity>
아로니아 식초는 초산 발효에 의해 갈변이 진행되므로 식초의 품질 특성을 조사하기 위해 16개 실험구의 색도를 측정하였다. 초산 발효액의 색도를 측정한 결과 명도인 L값은 47.58∼71.00, 적색도를 나타내는 a값은 31.77∼51.15, 황색도를 나타내는 b값은 18.45∼48.57이었다(표 3). 초산발효의 진행에 따라 초산이 많이 생성된 시료일수록 L값은 낮고 a값과 b값은 높은 경향이었으며 도 5의 pertubation plot과 반응표면곡선에서도 초기 아로니아 알코올 함량이 높을수록 L값은 감소하고 a값과 b값은 증가하는 경향이었다. 따라서 식초의 색도 변화는 초산발효의 원료와 균주, 발효 조건에 따라 달라질 수 있다고 생각되었다.In order to investigate the quality characteristics of vinegar, the chromaticity of sixteen specimens was measured. The L value of the acetic acid fermentation broth was 47.58 ~ 71.00, the a value was 31.77 ~ 51.15, and the b value was 18.45 ~ 48.57 (Table 3). The L value was lower and the a value and the b value were higher with increasing acetic acid fermentation. In the pertubation plot and the reaction surface curve of FIG. 5, the L value decreased as the initial ARA content was higher, Values and b values tended to increase. Therefore, the change of color of vinegar was thought to be dependent on the raw materials of acetic acid fermentation, strains, and fermentation conditions.
<아로니아 초산 발효 조건의 최적화> <Optimization of Aromatic Acid Fermentation Conditions>
아로니아 식초의 초산 발효 조건의 최적화를 위해 초기 알코올 함량과 초기 초산 농도, 초산균 접종량에 대한 접근은 canonical 모형의 수치 최적화(Numerical optimization)와 모형적 최적화(Graphical optimization)를 통해 선정하였다. 독립변수인 초기 알코올 농도와 초기 초산 농도, 초산균 접종량의 범위 내에서 유의적인 결과를 나타낸 반응변수 중 초산 생성량을 최대로, 잔류 알코올 함량과 pH를 최저로 설정하여 모델화에 의해 결정된 반응식을 이용하여 수치점을 예측하였다. 그 중 가장 높은 만족도를 갖는 최적점을 선택하여 지점 예측을 통해 도출하였으며, 예측된 최적값은 도 6과 도 7와 같이 초기 알코올 함량 7.78%, 초기 초산 농도 1.58%, 초산균 접종량 19.39%였다. 이와 같이 식초를 제조하고자 하는 원료와 초산균의 종류의 차이가 발효 조건에 영향을 주었음을 알 수 있다. In order to optimize the acetic acid fermentation conditions of Aronia vinegar, the initial alcohol content, initial acetic acid concentration, and the amount of inoculation of acetic acid bacteria were selected through numerical optimization and graphical optimization of the canonical model. Using the equation determined by modeling, we set the maximum amount of acetic acid production and the minimum amount of residual alcohol content and pH among the response variables that showed significant results within the range of initial alcohol concentration, initial acetic acid concentration, Point. 6 and 7, the initial optimum alcohol concentration was 7.78%, the initial acetic acid concentration was 1.58%, and the inoculation amount of acetic acid bacteria was 19.39%. Thus, it can be seen that the difference in the kinds of raw materials and acetic acid bacteria to be made vinegar influences the fermentation conditions.
<초산 발효 조건과 반응변수 사이의 상관관계> <Correlation between acetic acid fermentation conditions and response variables>
아로니아 식초의 초산 발효 조건인 초기 알코올 함량, 초기 초산 농도, 초산균 접종량과 반응변수인 초산 생성량, 잔류 알코올 함량, pH, 색도 값 사이의 상관관계를 분석한 결과(표 5) 발효초기 알코올 함량은 초산 생성량, pH, 적색도인 a값, 황색도인 b값과 양의 상관관계를 가지고 있고 잔류 알코올 함량, 명도 L값과 음의 상관관계에 있었다. 초기 초산농도는 초산 생성량과 양의 상관관계를 가지며 잔류 알코올 함량, pH와 음의 상관관계를 가지고 있었다. 따라서 아로니아의 초산발효에서 중요한 초산생성량과 발효액의 pH에는 초기 알코올 농도와 초산농도가 중요한 역할을 하는 것으로 생각되었다.The initial alcohol content, initial acetic acid concentration, acetic acid bacterial inoculation, acetic acid production, residual alcohol content, pH, and chromaticity values of the acornic acid fermentation conditions of Aronia vinegar were analyzed (Table 5) Acetic acid production, pH, a value of redness, and b value of yellowness, and negatively correlated with residual alcohol content and L value. Initial acetic acid concentration was positively correlated with acetic acid production and negative correlation with residual alcohol content and pH. Therefore, it was thought that the initial alcohol concentration and acetic acid concentration plays an important role in the acetic acid production and the pH of the fermentation broth in acorn acid fermentation of Aronia.
에탄올Early Aronia
ethanol
초산Early
Acetic acid
본 발명에서는 기능성 베리류인 아로니아 열매를 사용한 식초를 제조하기 위해 아로니아 열매로 알코올 발효액을 제조하였고, 초산 발효 조건의 최적화를 목적으로 반응표면 분석을 통해 시험구별로 제조된 초산 발효액의 특성을 조사한 후 최적 조건을 확립하고자 하였다. 식초 제조를 위해 아로니아 착즙액을 알코올 발효시킨 결과 8일 후 13.1%의 알코올이 생성되었다. 초산발효 조건 확립하기 위해 중심합성계획법에 따라 초기 알코올 함량, 초기 초산 농도, 초산균 접종량을 독립변수로 하여 실험을 계획하였고, 발효액의 특성을 반응변수로 하여 분석한 후 발효 조건을 최적화하였다. 초산 생성량, 잔류 알코올 함량, pH, 색도(L, a, b)는 반응표면 분석 결과 0.92∼0.99이었고, p value 결과 0.0001 이하로 모두 유의성이 인정되었다. 14일간의 초산 발효 후 16개 실험구의 초산생성량은 26.34~57.82 g/L였고, 잔류 알코올 함량은 0.80~1.53%였으며 pH는 3.19~3.43이었다. 색도는 초산발효 진행에 따라 명도는 낮아지고 적색도와 황색도는 증가하였다. 분석 결과 아로니아 식초의 초산발효 최적조건은 초기 알코올 함량 7.78%, 초기 초산 농도 1.58%, 초산균 접종량 19.39%였으며, 초기 알코올 함량은 초산생성량, pH, 적색도, 황색도와 양의 상관관계를 보였고 잔류 알코올 함량과 명도와는 음의 상관관계를 나타내었다. 이상의 결과로부터 식초의 초산 발효에는 초기 알코올 함량과 초산 농도가 식초 발효에 중요한 영향을 미치므로 발효 초기 알코올과 초산이 적정 농도 이상으로 함유되어 있어야 초산균이 활성화 되는 데 도움을 주어 원활한 초산 발효가 일어날 수 있다는 것을 알 수 있다. 본 발명을 토대로 아로니아 식초 제조의 최적 조건을 확립하여 표준화된 방법으로 식초 제조를 할 수 있을 것 이라고 생각된다.In the present invention, an alcohol fermentation broth was prepared from Aronia broth to produce vinegar using the functional beryl, Aronia fruit, and the characteristics of the acetic acid fermentation broth prepared by the test for the purpose of optimization of acetic acid fermentation conditions were investigated And to establish the optimal conditions. Alcohol fermentation of Aronia juice for vinegar production resulted in 13.1% alcohol after 8 days. In order to establish acetic acid fermentation conditions, experiments were planned with the initial alcohol content, initial acetic acid concentration, and inoculation amount of acetic acid bacteria as independent variables according to the central synthetic design method, and the fermentation conditions were optimized after analyzing the characteristics of the fermentation broth as response variables. Acetic acid production, and the residual alcohol content, pH, color (L, a, b) was a response surface analysis 0.92~0.99, p value was significant result or both of 0.0001 or less. After 14 days of acetic acid fermentation, the amount of acetic acid produced in 16 experimental groups was 26.34 ~ 57.82 g / L, the residual alcohol content was 0.80 ~ 1.53% and the pH was 3.19 ~ 3.43. As the acetic acid fermentation progressed, the lightness decreased and the redness and yellowing increased. The optimum conditions of acaric acid fermentation of Aronia vinegar were 7.78% in initial alcohol content, 1.58% in initial acetic acid concentration and 19.39% in inoculation rate of acetic acid bacteria. The initial alcohol content showed a positive correlation with acetic acid production, pH, Alcohol content and lightness showed a negative correlation. These results suggest that the initial alcohol content and acetic acid concentration of vinegar have an important influence on vinegar fermentation. Therefore, it is necessary that the initial concentration of alcohol and acetic acid is contained in the proper amount to help acetic acid bacteria to be activated, . Based on the present invention, it is considered that vinegar can be produced by standardized method by establishing optimal conditions for producing vinegar of Aronia.
<적용예 1-4> 아로니아식초 음료<Application example 1-4> Aronia vinegar drink
본 발명에서 얻은 아로니아식초를 이용하여 다음 표 6과 같이 식초음료를 만들고 자 하였다. 정제수 100중량부에 대하여 아로니아 식초 1∼5중량부, 비타민은 비타민 C, 비타민 B 복합체, 비오틴, 폴산, 콜린, 이노시톨 중에서 선택된 어느하나 이상으로 0.01∼0.1중량부, 과일농축액은 사과농축액, 배농축액, 키위농축액, 바나나농축액, 파인애플농축액, 자두농축액, 살구농축액, 복숭아농축액, 멜론농축액, 망고농축액, 포도농축액, 블루베리농축액, 오렌지농축액, 매실농축액, 레몬농축액 중에서 선택된 어느 하나 이상으로 1∼10중량부, 당류는 설탕, 포도당, 과당, 엿류, 이소말토올리고당, 프락토올리고당, 키토올리고당, 자일로올리고당, 꿀, 프로폴리스, 트레할로스, 솔비톨, 자일리톨, 만니톨, 이노시톨, 에리스리톨 중에서 어느 하나 이상 1∼10중량부, 기능성 성분의 추출물로 옥수수수염, 마가목, 감마오리자놀, 스쿠알렌, 스피룰리나, 클로렐라, 구아바잎, 녹차, 식이섬유, 히알루론산나트륨, N-아세틸 글루코사민, 이눌린, 차전자피 및 카제인가수분해물의 군으로부터 선택된 어느 하나 이상 0.5∼3중량부 및 잔부의 정제수를 혼합하고 여과 및 고온순간 살균하여 밀봉하였다.Using the Aronia vinegar obtained in the present invention, a vinegar drink was prepared as shown in Table 6 below. 0.01 to 0.1 part by weight of at least one selected from the group consisting of vitamin C, vitamin B complex, biotin, folic acid, choline and inositol, and the fruit concentrate is an apple concentrate, Wherein the concentrate is at least one selected from the group consisting of a concentrate, a kiwi concentrate, a banana concentrate, a pineapple concentrate, a plum concentrate, an apricot concentrate, a peach concentrate, a melon concentrate, a mango concentrate, a grape concentrate, a blueberry concentrate, an orange concentrate, The saccharide is one or more of one or more of sugar, glucose, fructose, maltose, isomaltooligosaccharide, fructooligosaccharide, chito oligosaccharide, xylooligosaccharide, honey, propolis, trehalose, sorbitol, xylitol, mannitol, inositol, erythritol. 10 parts by weight of an extract of a functional ingredient, corn shaved bean curd, gamma oruzanol, squalene, spirulina, chlorella, 0.5 to 3 parts by weight of at least one member selected from the group consisting of Ava leaf, green tea, dietary fiber, sodium hyaluronate, N-acetylglucosamine, inulin, ketchup and casein hydrolyzate and the remaining purified water are mixed and filtrated and hot- Respectively.
<시험예>; 식초음료의 관능검사≪ Test Example > Sensory evaluation of vinegar drinks
적용예 1-4와 같이 만든 아로니아식초 음료를 대상으로 시중에서 판매되고 있는 식초음료(O사제품)와 잘 훈련된 Panel로 하여금 5점척도법으로 관능검사(10대, 20대, 30대 남녀 각 2명)를 실시하여 그 결과를 다음의 표 7에 나타냈다. A vinegar drink (O company) and a well-trained panel sold on the market for the Aronia vinegar drink prepared in Application Example 1-4 were subjected to a sensory test by a 5-point scale (10, 20, The results are shown in Table 7 below.
상기의 관능검사 결과로부터 본 발명의 아로니아식초 음료가 시중에서 유통되고 있는 식초음료보다 신맛, 개운한맛, 뒷맛, 기호도 면에서 우수한 것으로 나타났다.From the above sensory evaluation results, the Aronia vinegar drink of the present invention was found to be superior in sourness, refreshing taste, aftertaste, and taste than the vinegar drink marketed in the market.
본 발명의 아로니아 식초는 기능성 성분인 안토시아닌과 폴리페놀이 함유되어 있어 항산화 효과, 시력회복 효과, 혈관질환 예방 효과, 뇌질환의 예방과 치료 효과, 당뇨 예방 효과, 면역력 증진 효과, 다이어트 효과 등이 있으므로 건강 음료로 제공될 수 있다.The vinegar of the present invention contains an anthocyanin and a polyphenol which are functional ingredients, and can be used for antioxidant effect, vision recovery effect, vascular disease prevention effect, prevention and treatment effect of brain disease, diabetes prevention effect, immunity enhancement effect, Therefore, it can be provided as a health drink.
초산 발효는 초기 에탄올과 초산이 적정 농도 이상으로 함유되어 있어야 초산균이 활성화 되어 원활한 초산 발효가 일어난다.
Acetic acid fermentation requires that the initial concentration of ethanol and acetic acid be contained at an appropriate concentration or higher so that acetic acid bacteria are activated and smooth acetic acid fermentation occurs.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140195266A KR20160082162A (en) | 2014-12-31 | 2014-12-31 | Method for Venegar Using Aronia and Venegar Beverage Using Thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140195266A KR20160082162A (en) | 2014-12-31 | 2014-12-31 | Method for Venegar Using Aronia and Venegar Beverage Using Thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20160082162A true KR20160082162A (en) | 2016-07-08 |
Family
ID=56504166
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020140195266A Ceased KR20160082162A (en) | 2014-12-31 | 2014-12-31 | Method for Venegar Using Aronia and Venegar Beverage Using Thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20160082162A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190044202A (en) * | 2017-10-20 | 2019-04-30 | 주식회사 제주자연초 농업회사법인 | Method for manufacturing fruit vinegar |
KR20220099855A (en) * | 2021-01-07 | 2022-07-14 | 재단법인 순천바이오헬스케어연구센터 | Composition for anti-inflammation comprising Aronia vinegar |
-
2014
- 2014-12-31 KR KR1020140195266A patent/KR20160082162A/en not_active Ceased
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190044202A (en) * | 2017-10-20 | 2019-04-30 | 주식회사 제주자연초 농업회사법인 | Method for manufacturing fruit vinegar |
KR20220099855A (en) * | 2021-01-07 | 2022-07-14 | 재단법인 순천바이오헬스케어연구센터 | Composition for anti-inflammation comprising Aronia vinegar |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104232422B (en) | A kind of brewing method of blueberry fruit wine | |
CA2695445C (en) | Chlorella extract-containing product and method for improving the storage stability of the same | |
KR100988387B1 (en) | Manufacturing method of fermented alcohol using a wild pear | |
KR101902209B1 (en) | Fermented composition of native grass, vegetable and sugar cane molasses with enhanced palatability and bioactive substances | |
KR101859929B1 (en) | Wine and vinegar with high taste and flavor and functionality from mixtures of kiwi-fruit, persimmon and wild grapes, and preparation method thereof | |
KR20080103258A (en) | Yeon wine and its manufacturing method | |
CN102943025A (en) | Lycium ruthenicum murr. vinegar preparation method | |
KR101690413B1 (en) | Manufacturing method of vinegar using aronia berry | |
KR20200038724A (en) | Fermented vinegar using unripe apple jin-hong and use thereof | |
KR101872128B1 (en) | A preparation method of fermented onion composition for enhancing immune activity | |
CN105238635A (en) | Brewing technology of orange wine | |
CN111154594A (en) | Lemon and snow pear compound wine and brewing method thereof | |
KR101330274B1 (en) | Fermented Carbonated Beverage Manufacturing Method Using Fermentation Process of Natural Materials | |
KR20160021643A (en) | Manufacturing Method of Beverage Using Extract from Aronia | |
KR20160082162A (en) | Method for Venegar Using Aronia and Venegar Beverage Using Thereof | |
KR100543776B1 (en) | How to make Odyssey | |
KR102177465B1 (en) | Citrus and Red Beet vinegar and method for manufacturing the same | |
KR101733549B1 (en) | Wine or vinegar of Orostachys japonicus made from fermented sugar extract of Orostachys japonicus | |
KR101397405B1 (en) | Preparing method of concentrated extract of rubus coreanus using rubus coreanus jubak (alcohol filter cake) | |
KR20170070873A (en) | Berry jam including sorghum syrup and apple concentrate and manufacturing method thereof | |
KR20230080923A (en) | Method for producing a ferment extract of the centella asiatica and composition for antiocidative comprising the ferment extract of the centella asiatica produced by the same | |
KR101978989B1 (en) | Manufacturing method of aronia wine | |
KR20160039858A (en) | Persimmon wine containig aronia and process for preparing thereof | |
KR102154716B1 (en) | The fermented vinegar containing strawberry and honey, and its producing method | |
CN115678702B (en) | Method for brewing wine and wine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20141231 |
|
PA0201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20160523 Patent event code: PE09021S01D |
|
PG1501 | Laying open of application | ||
E601 | Decision to refuse application | ||
PE0601 | Decision on rejection of patent |
Patent event date: 20161229 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20160523 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |